We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Bernard Scheuble has stepped down as chief executive of German drugmaker Merck KGaA, effective immediately, the company announced last week. Vice Chairman Michael Roemer was named to replace Scheuble as chairman of the executive board.